首页|基于网络药理学探究"葫芦巴-迷迭香"提取物治疗Ⅱ型糖尿病的潜在作用机制及实验验证

基于网络药理学探究"葫芦巴-迷迭香"提取物治疗Ⅱ型糖尿病的潜在作用机制及实验验证

扫码查看
(目的)利用网络药理学相关技术,分析中药"葫芦巴-迷迭香"提取物治疗Ⅱ型糖尿病的潜在作用机制.(方法)构建活性物质、活性靶点和疾病相关靶点的网络药理图,通过网络分析阐释其作用机制.选取50 只SD大鼠,随机分为空白组、Ⅱ型糖尿病模型组及"葫芦巴-迷迭香"提取物高、中、低剂量治疗组,每组10 只.试剂盒检测大鼠血清中总甘油三脂、总胆固醇、高密度脂蛋白胆固醇和低密度脂蛋白胆固醇的含量,ELISA法检测各组大鼠血清中白细胞介素 IL-6、IL-2、肿瘤坏死因子(TNF)-α、血管内皮生长因子(VEGF)和表皮细胞生长因子(EGF)表达情况.(结果)"葫芦巴-迷迭香"筛选得到56 个活性成分及764 个治疗Ⅱ型糖尿病潜在相关靶点.蛋白相互作用分析提示 FGFR1、TNF、INSR、IL-6、MAPK14、JUN、PPARA、VEGFA、PTPN1、PTPN2、IGF1R、PTPN11 为关键靶点.动物实验表明"葫芦巴-迷迭香"提取物给药中、高剂量组可显著降低血清中的甘油三酯和胆固醇,上调高密度脂蛋白胆固醇的含量,下调低密度脂蛋白胆固醇的含量,调节炎性因子TNF-α、IL-6、IL-2 的含量,提高VEGF和EGF的表达.(结论)较为系统地解析了"葫芦巴-迷迭香"提取物治疗Ⅱ型糖尿病的作用机制,为中医药治疗Ⅱ型糖尿病和中药新药的研发奠定了基础.
Explore the Potential Mechanism of Action and Experimental Verification of"Fenugreek Rosemary"Extract in the Treatment of Type 2 Diabetes Mellitus Based on Network Pharmacology
Objective:To analyze the potential mechanism of traditional Chinese medicine"trigonella-rosemary"in the treatment of type Ⅱ dia-betes mellitus(T2DM)by using network pharmacology related technology.Methods:The chemical components and their targets of chinese me-dicinal herbs were collected by searching the c hinese medicine database,and the targets related to type Ⅱ diabetes were searched by searching the disease target database.The network pharmacological map of active substances,active targets and disease-related targets was constructed,and the mechanism of action was explained by network analysis.Fifty SD rats were randomly divided into blank group,type 2 diabetes model group and"fenugreek rosemary"extract high-dose,medium-dose and low-dose treatment groups with 10 rats per group.The contents of to-tal triglycerides,total cholesterol,high density lipoprotein and low density lipoprotein in serum of rats were detected by the kit.The expression levels of TNF-α,IL-6,IL-2,VEGF and EGF were detected by ELISA.Results:A total of 56 active ingredients and 764 potential targets for the treatment of typeⅡdiabetes were identified from"Trigonella-rosemary".Protein interaction analysis showed that FGFR1,TNF,INSR,IL-6,MAPK14,JUN,PPARA,VEGFA,PTPN1,PTPN2,IGF1R and PTPN11 were the key targets.Animal experiments showed that the medium and high dose groups of fenugreek rosemary extract could significantly reduce the serum triglyceride and cholesterol,up-regulate the serum high density lipoprotein content,down-regulate the serum low density lipoprotein content,regulate the inflammatory factors TNF-α,IL-6,IL-2 content,and increase the expression of VEGF and EGF.Conclusion:This study systematically analyzed the mechanism of action of"trigonella-rosemary"in the treatment of type Ⅱ diabetes,and laid the foundation for the treatment of type Ⅱ diabetes with traditional chinese medicine and the research and development of new chinese medicine.

network pharmacologytype 2 diabetes mellitustrigonellarosemary

张彦昕、柴贝贝、石玉节、李海利

展开 >

郑州赛科药业科技有限公司, 河南 郑州 450000

河南省农业科学院畜牧兽医研究所, 河南 郑州 450000

网络药理学 Ⅱ型糖尿病 葫芦巴 迷迭香

河南省科技攻关项目郑州市高端外国专家技术合作项目

182102410038YZ22JSHZ021

2024

云南化工
云南省化工研究院 云天化集团有限责任公司 云南煤化工集团有限公司 云南省化学化工学会

云南化工

影响因子:0.272
ISSN:1004-275X
年,卷(期):2024.51(2)
  • 35